Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,655
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
for
Thoracic
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT06075316
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
for
Acute Myeloid Leukemia With FLT3/ITD Mutation,
Location: Chapel Hill NC, Philadelphia PA, Columbus OH,
Sponsor: Uma Borate
Sex: All
Age: 18+
Code: NCT06222580
Phase 1, Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Chapel Hill NC, Norfolk VA, Philadelphia PA, Atlanta GA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
for
Recurrent Melanoma (Skin), Metastatic Melanoma,
Location: Chapel Hill NC, Pittsburgh PA, Philadelphia PA,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05655312
Phase 1, Phase 2, Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Hillsborough NC, New Brunswick NJ, New York NY, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase 1, Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: Chapel Hill NC, Pittsburgh PA, Jacksonville FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase 1, Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Chapel Hill NC, Richmond VA, Baltimore MD,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
for
Surgery, Pain, Postoperative
Location: Chapel Hill NC, Camden NJ, Philadelphia PA, Detroit MI,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05722002
Recruiting
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Chapel Hill NC, Richmond VA, Cincinnati OH,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Chapel Hill NC, Fairfax VA, Washington D.C. DC,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
for
Pancreatic Ductal Adenocarcinoma
Location: Chapel Hill NC, Philadelphia PA, New York NY,
Sponsor: Gulam Manji
Sex: All
Age: 18+
Code: NCT06048484
Phase 2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Chapel Hill NC, Richmond VA, Pittsburgh PA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Optimal Ventilation for Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Wilmington DE,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07114510
Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Chapel Hill NC, Charlottesville VA, Asheville NC,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Fayetteville NC, Roanoke VA, Greenville SC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight